Epion Therapeutics
MA - BurlingtonBiotechnology
Focus: Epion Therapeutics is a biotech company focused on minimally-invasive drug-device combinations for keratoconus, a progressive corneal disease. The company is based in Burlington, MA and operates at the pre-revenue or early-stage biotech level.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Epion Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Epion Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment
KeratoconusClinical Trials (1)
NCT06100952Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
Phase 3Help build intelligence for Epion Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.